Slawin KM - Search Results

1

Variation in prostate specific antigen results from 2 different assay platforms: clinical impact on 2304 patients undergoing prostate cancer screening.

Link RE, Shariat SF, Nguyen CV, Farr A, Weinberg AD, Morton RA, Richardson B, Bernard D, Slawin KM. Link RE, et al. Among authors: slawin km. J Urol. 2004 Jun;171(6 Pt 1):2234-8. doi: 10.1097/01.ju.0000127736.86597.e7. J Urol. 2004. PMID: 15126793

2

Biochemical staging of prostate cancer.

Canto EI, Shariat SF, Slawin KM. Canto EI, et al. Among authors: slawin km. Urol Clin North Am. 2003 May;30(2):263-77. doi: 10.1016/s0094-0143(02)00183-0. Urol Clin North Am. 2003. PMID: 12735503 Review.

3

Association of plasma urokinase-type plasminogen activator and its receptor with clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder.

Shariat SF, Monoski MA, Andrews B, Wheeler TM, Lerner SP, Slawin KM. Shariat SF, et al. Among authors: slawin km. Urology. 2003 May;61(5):1053-8. doi: 10.1016/s0090-4295(02)02522-0. Urology. 2003. PMID: 12736046

4

Early postoperative peripheral blood reverse transcription PCR assay for prostate-specific antigen is associated with prostate cancer progression in patients undergoing radical prostatectomy.

Shariat SF, Kattan MW, Song W, Bernard D, Gottenger E, Wheeler TM, Slawin KM. Shariat SF, et al. Among authors: slawin km. Cancer Res. 2003 Sep 15;63(18):5874-8. Cancer Res. 2003. PMID: 14522912

5

Preoperative plasma soluble E-cadherin predicts metastases to lymph nodes and prognosis in patients undergoing radical cystectomy.

Matsumoto K, Shariat SF, Casella R, Wheeler TM, Slawin KM, Lerner SP. Matsumoto K, et al. Among authors: slawin km. J Urol. 2003 Dec;170(6 Pt 1):2248-52. doi: 10.1097/01.ju.0000094189.93805.17. J Urol. 2003. PMID: 14634390

6

Six additional systematic lateral cores enhance sextant biopsy prediction of pathological features at radical prostatectomy.

Singh H, Canto EI, Shariat SF, Kadmon D, Miles BJ, Wheeler TM, Slawin KM. Singh H, et al. Among authors: slawin km. J Urol. 2004 Jan;171(1):204-9. doi: 10.1097/01.ju.0000100220.46419.8b. J Urol. 2004. PMID: 14665877

7

Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy.

Singh H, Canto EI, Shariat SF, Kadmon D, Miles BJ, Wheeler TM, Slawin KM. Singh H, et al. Among authors: slawin km. J Urol. 2004 Mar;171(3):1089-92. doi: 10.1097/01.ju.0000112763.74119.d4. J Urol. 2004. PMID: 14767277

8

Predictors of prostate cancer after initial negative systematic 12 core biopsy.

Singh H, Canto EI, Shariat SF, Kadmon D, Miles BJ, Wheeler TM, Slawin KM. Singh H, et al. Among authors: slawin km. J Urol. 2004 May;171(5):1850-4. doi: 10.1097/01.ju.0000119667.86071.e7. J Urol. 2004. PMID: 15076292

9

Serum BPSA outperforms both total PSA and free PSA as a predictor of prostatic enlargement in men without prostate cancer.

Canto EI, Singh H, Shariat SF, Lamb DJ, Mikolajczyk SD, Linton HJ, Rittenhouse HG, Kadmon D, Miles BJ, Slawin KM. Canto EI, et al. Among authors: slawin km. Urology. 2004 May;63(5):905-10; discussion 910-1. doi: 10.1016/j.urology.2003.12.037. Urology. 2004. PMID: 15134977

10

Molecular diagnosis of prostate cancer.

Canto EI, Shariat SF, Slawin KM. Canto EI, et al. Among authors: slawin km. Curr Urol Rep. 2004 Jun;5(3):203-11. doi: 10.1007/s11934-004-0038-2. Curr Urol Rep. 2004. PMID: 15161569 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters